Diversified Trust Co held its position in HealthSouth Corp. (NYSE:HLS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,410 shares of the company’s stock at the end of the second quarter. Diversified Trust Co’s holdings in HealthSouth Corp. were worth $365,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of HLS. AMP Capital Investors Ltd increased its position in HealthSouth Corp. by 10.4% in the first quarter. AMP Capital Investors Ltd now owns 98,600 shares of the company’s stock worth $3,680,000 after buying an additional 9,300 shares during the period. Nuveen Asset Management LLC increased its position in HealthSouth Corp. by 3.7% in the first quarter. Nuveen Asset Management LLC now owns 69,892 shares of the company’s stock worth $2,630,000 after buying an additional 2,517 shares during the period. Renaissance Technologies LLC increased its position in HealthSouth Corp. by 321.1% in the first quarter. Renaissance Technologies LLC now owns 638,400 shares of the company’s stock worth $24,023,000 after buying an additional 486,800 shares during the period. State Street Corp increased its position in HealthSouth Corp. by 3.4% in the first quarter. State Street Corp now owns 1,880,351 shares of the company’s stock worth $70,753,000 after buying an additional 61,337 shares during the period. Finally, Credit Agricole S A increased its position in HealthSouth Corp. by 432.2% in the first quarter. Credit Agricole S A now owns 227,800 shares of the company’s stock worth $8,572,000 after buying an additional 185,000 shares during the period. 94.94% of the stock is currently owned by institutional investors and hedge funds.
Shares of HealthSouth Corp. (NYSE:HLS) traded up 0.34% during trading on Wednesday, reaching $41.10. The company’s stock had a trading volume of 711,521 shares. The firm’s 50-day moving average price is $40.80 and its 200-day moving average price is $39.65. The company has a market capitalization of $3.69 billion, a price-to-earnings ratio of 18.04 and a beta of 1.31. HealthSouth Corp. has a one year low of $30.26 and a one year high of $43.38.
HealthSouth Corp. (NYSE:HLS) last posted its quarterly earnings data on Thursday, July 28th. The company reported $0.69 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.09. The business had revenue of $920.70 million for the quarter, compared to analysts’ expectations of $906.67 million. HealthSouth Corp. had a return on equity of 28.99% and a net margin of 6.26%. The business’s revenue was up 20.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.47 EPS. On average, equities analysts anticipate that HealthSouth Corp. will post $2.52 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 2.34%. This is a boost from HealthSouth Corp.’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Thursday, September 29th. HealthSouth Corp.’s payout ratio is presently 40.53%.
Several analysts have recently commented on HLS shares. Zacks Investment Research downgraded HealthSouth Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. SunTrust Banks Inc. set a $54.00 price objective on HealthSouth Corp. and gave the stock a “buy” rating in a research note on Monday, August 1st. JMP Securities reissued a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 4th. Wells Fargo & Co. reissued a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 11th. Finally, Barclays PLC downgraded HealthSouth Corp. from an “equal weight” rating to an “underweight” rating and lowered their price objective for the stock from $45.00 to $42.00 in a research note on Monday, June 27th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $46.00.
In other HealthSouth Corp. news, COO Mark J. Tarr sold 20,000 shares of HealthSouth Corp. stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $41.85, for a total transaction of $837,000.00. Following the sale, the chief operating officer now directly owns 252,519 shares of the company’s stock, valued at approximately $10,567,920.15. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 5.00% of the company’s stock.
HealthSouth Corp. Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp. (NYSE:HLS).
Receive News & Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.